|

Pimicotinib (ABSK021) Clinical Trials

1 actively recruiting trial

Also known as: Gemcitabine, Toripalimab, nab-Pacilitaxel

Pipeline

Phase 2: 1

Top Sponsors

  • Abbisko Therapeutics Co, Ltd1

Indications

  • Advanced Pancreatic Cancer1
  • Cancer1

Other1 trial

A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.